InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by FARRELL PETER C, Director. Insider active across 2 companies, notably RESMED INC. Aggregated, 8 reports have been published. The latest transaction was filed on 24 January 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations8 total
015,568 shares0
Common Stock
SEC:0001570562-22-000048:0·
015,568 shares0
Common Stock
SEC:0001570562-22-000048·
0478 shares0
ResMed Common Stock
SEC:0000943819-21-000037·
0478 shares0
ResMed Common Stock
SEC:0000943819-21-000037:0·
€77,259342 shares@ €225.90240.0002% mcap100.0% of flow
ResMed Common Stock
SEC:0001127602-21-029094·
€77,259342 shares@ €225.90240.0002% mcap50.0% of flow
ResMed Common Stock
SEC:0001127602-21-029094:0·
036,670 shares0
ResMed Common Stock
SEC:0001127602-21-023942·
036,670 shares0
ResMed Common Stock
SEC:0001127602-21-023942:0·
8 of 8 declarations
About FARRELL PETER C
Peter C. Farrell is a Director at ResMed Inc and Evolus, Inc. He contributes to the governance of these companies by providing his expertise and advice to the board of directors. His role involves overseeing operations and ensuring that decisions made are in the best interest of shareholders.
